Tirat Carmel, January 2024 - The UK's medical imaging market is on a strong growth trajectory, fuelled by the increasing incidence of chronic diseases, an aging population, and significant advancements in MRI technology. Valued at USD 13.25 billion (2021) , the market is projected to expand at a compound annual growth rate (CAGR) of 6.9% through 2030. This growth is largely driven by a growing demand for advanced diagnostic imaging tools, particularly in the MRI segment.

Medic Vision's iQMR® is an innovative AI-assisted solution for the medical imaging industry. Recognized for its ability to enhance MRI image quality, iQMR® enables 40% faster MRI scans and a significant 35% increase in productivity. Its vendor-neutral image enhancement capabilities make iQMR® an essential tool for imaging departments and practices looking to upgrade their MRI scanners in order to meet the rising demands in the UK’s healthcare sector.

Gil Shetrit, CEO of Medic Vision: "The introduction of iQMR® to the UK is a significant step in our global strategy, and we anticipate it will be met with great success. Its proven track record in the US, where it has been widely adopted by numerous hospitals and imaging centers, is a testament to its reliability and effectiveness.
The positive reactions we've received from UK imaging centers reinforce our belief in the potential for iQMR® in this new market. We are confident that it will be a valuable tool for healthcare professionals, helping them overcome challenges such as staffing shortages and increasing MRI demands, and ultimately enhancing patient care."


About Medic Vision:
Medic Vision is the leading innovator of vendor-independent, image enhancement, productivity, and compliance solutions for CT and MRI scanners. Its innovative, FDA-approved, products are based on generative artificial intelligence reconstruction algorithms and are in clinical use at numerous hospitals and imaging centers around the world.

MRI Homepage